EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options

Eguzkiñe Diez-Martin iD, Leidi Hernandez-Suarez iD, Carmen Muñoz-Villafranca, Leire Martin-Souto iD, Egoitz Astigarraga iD, Andoni Ramirez-Garcia iD, Gabriel Barreda-Gómez iD

International Journal of Molecular Sciences · 27.06.2024 · 25 (13) · 7062

DOI: 10.3390/ijms25137062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2024. Verfasst von Eguzkiñe Diez-Martin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Department, IMG Pharma Biotech S.L., 48170 Zamudio, Spain. Hauptthemen laut MEDLINE: Biomarkers, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 294 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basque Government Department of Economic Development, Sustainability and Environment Bikaintek program, the University of the Basque Country, UPV/EHU, post-doctoral funding for doctoral Research Staff Improvement by the Basque Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In inflammatory bowel diseases (IBDs), such as Crohn’s disease (CD) and ulcerative colitis (UC), the immune system relentlessly attacks intestinal cells, causing recurrent tissue damage over the lifetime of patients. The etiology of IBD is complex and multifactorial, involving environmental, microbiota, genetic, and immunological factors that alter the molecular basis of the organism. Among these, the microbiota and immune cells play pivotal roles; the microbiota generates antigens recognized by immune cells and antibodies, while autoantibodies target and attack the intestinal membrane, exacerbating inflammation and tissue damage. Given the altered molecular framework, the analysis of multiple molecular biomarkers in patients proves exceedingly valuable for diagnosing and prognosing IBD, including markers like C reactive protein and fecal calprotectin. Upon detection and classification of patients, specific treatments are administered, ranging from conventional drugs to new biological therapies, such as antibodies to neutralize inflammatory molecules like tumor necrosis factor (TNF) and integrin. This review delves into the molecular basis and targets, biomarkers, treatment options, monitoring techniques, and, ultimately, current challenges in IBD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersInflammatory Bowel DiseasesHumansAnimals

Stichwörter der Autor:innen

Crohn’s diseaseantibodiesbiomarkersenvironmentalgeneticimmunityinflammatory bowel diseasemicrobiotamolecular mechanismstherapeutic targetsulcerative colitis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Research and Development Department, IMG Pharma Biotech S.L., 48170 Zamudio, Spain.
  • Department of Immunology, Microbiology and Parasitology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
  • Department of Gastroenterology, University Hospital of Basurto, Avda Montevideo 18, 48013 Bilbao, Spain.

ORCID-Profile: Eguzkiñe Diez-Martin, Leidi Hernandez-Suarez, Leire Martin-Souto, Egoitz Astigarraga, Andoni Ramirez-Garcia, Gabriel Barreda-Gómez

Förderung

  • Basque Government Department of Economic Development, Sustainability and Environment Bikaintek program
  • the University of the Basque Country, UPV/EHU
  • post-doctoral funding for doctoral Research Staff Improvement by the Basque Government
  • University of the Basque Country, UPV/EHU

Zitieren

APA

Diez-Martin, E., Hernandez-Suarez, L., Muñoz-Villafranca, C., Martin-Souto, L., Astigarraga, E., Ramirez-Garcia, A., & Barreda-Gómez, G. (2024). Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. International Journal of Molecular Sciences, 25(13), 7062. https://doi.org/10.3390/ijms25137062

Vancouver

Diez-Martin E, Hernandez-Suarez L, Muñoz-Villafranca C, Martin-Souto L, Astigarraga E, Ramirez-Garcia A, et al. Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options. International Journal of Molecular Sciences. 2024;25(13):7062. doi:10.3390/ijms25137062

BibTeX
@article{DiezMartin2024,
  author = {Diez-Martin, Eguzkiñe and Hernandez-Suarez, Leidi and Muñoz-Villafranca, Carmen and Martin-Souto, Leire and Astigarraga, Egoitz and Ramirez-Garcia, Andoni and Barreda-Gómez, Gabriel},
  title = {Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {7062},
  doi = {10.3390/ijms25137062}
}
Kostenlos starten →